Skip to main content

JPMORGAN CHASE & CO

Position in JANX — Janux Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in JANX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$3,186,822
+$833,799 QoQ
Shares Held
229,268
+34.5% QoQ
Ownership
0.376%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 74% Shared 0% None 26%

Common Shares in JANX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. JANX ranks #122 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JANX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,186,822 229,268
2025-12-31 $2,353,023 170,509
2025-09-30 $5,112,428 209,183
2025-06-30 $5,715,490 247,424
2025-03-31 $3,653,316 135,308
2024-12-31 $10,258,422 191,603
2024-09-30 $835,545 18,392
2024-06-30 $804,830 19,213
2024-03-31 $728,261 19,343
2023-12-31 $190,306 17,736
2023-09-30 $1,497,977 148,609
2023-06-30 $1,821,282 153,436
2023-03-31 $1,568,848 129,657
2022-12-31 $1,366,820 103,783
2022-09-30 $1,422,415 105,053
2022-06-30 $1,263,464 103,478
2022-03-31 $257,057 17,926
2021-12-31 $262,169 13,288
2021-09-30 $140,031 6,474
2021-06-30 $16,117 646